Multicenter randomized, and blinded European field study evaluating the efficacy and safety of Felpreva®, a novel spot-on formulation containing tigolaner, emodepside and praziquantel, in treating cats with mixed infection with intestinal nematodes, cestodes and/or lungworms

Multicenter randomized, and blinded European field study evaluating the efficacy and safety of Felpreva®, a novel spot-on formulation containing tigolaner, emodepside and praziquantel, in treating cats with mixed infection with intestinal nematodes, cestodes and/or lungworms

This paper describes a multicentric field study which has evaluated the safety and efficacy of a novel spot on formulation containing emodepside 2.04% w/v, praziquantel 8.14% w/v and tigolaner 9.79% w/v (Felpreva®, Vetoquinol) when administered at the intended commercial dose of 0.15 ml/kg body weig...

Full description

Bibliographic Details
Main Authors: Dejan Cvejić, Norbert Mencke, Gabriele Petry, Hannah Ringeisen, Hannah Hamburg, Klaus Hellmann, Donato Traversa, Simone Morelli, Angela Di Cesare, Anastasia Diakou, Róbert Farkas
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Current Research in Parasitology and Vector-Borne Diseases
Subjects:
Cat
Felpreva®
Intestinal helminths
Lungworms
Treatment
Online Access:http://www.sciencedirect.com/science/article/pii/S2667114X22000243

Similar Items

Similar Items